  Aims: Ischaemic cardiomyopathy (ICM) leads to impaired contraction and
ventricular dysfunction causing high rates of morbidity and mortality.
Epigenomics allows the identification of epigenetic signatures in human
diseases. We analyse the differential epigenetic patterns of ASB gene family in
ICM patients and relate these alterations to their haemodynamic and functional
status. Methods and Results: Epigenomic analysis was carried out using 16 left
ventricular (LV) tissue samples, 8 from ICM patients undergoing heart
transplantation and 8 from control (CNT) subjects without cardiac disease. We
increased the sample size up to 13 ICM and 10 CNT for RNA-sequencing and to 14
ICM for pyrosequencing analyses. We found a hypermethylated profile
(cg11189868) in the ASB1 gene that showed a differential methylation of 0.26
beta difference, P < 0.05. This result was validated by pyrosequencing
technique (0.23 beta difference, P < 0.05). Notably, the methylation pattern
was strongly related to LV ejection fraction (r = -0.849, P = 0.008) stroke
volume (r = -0.929, P = 0.001) and end-systolic and diastolic LV diameters (r =
-0.743, P = 0.035 for both). ASB1 showed a down regulation in mRNA levels (-1.2
fold, P < 0.05). Conclusion: Our findings link a specific ASB1 methylation
pattern to LV structure and performance in end-stage ICM, opening new
therapeutic opportunities and providing new insights regarding which is the
functionally relevant genome in the ischemic failing myocardium. Keywords:
ischaemic cardiomyopathy; epigenomics; heart failure; left ventricular
dysfunction; stroke volume; ASB1.
